CordenPharma Oligonucleotide Platform

CordenPharma Oligonucleotide Platform

Products
CordenPharma Oligonucleotide Platform
CordenPharma Oligonucleotide Platform

Information

Your Expert Partner for Oligonucleotide APIs Process Development & Small-scale: scale-up to 10 mmol per run(small-scale equipment can also support early-stage supply) Scale-up & Small to Medium-scale: scale-up to 100 mmol per run(supported by OligoPilotTM equipment) Large-Scale Oligonucleotide Process Equipment: allows fully-automated manufacturing at a scale-up to 1800 mmol per batch (supported by OligoProcessTM equipment) Downstream Processing Capabilities: For each of the above-mentioned process stages, multiple sets are available for streamlined and cost-effective manufacturing Fully-Integrated service offering from API to finished dosage and pharmaceutical services
Main Categories
Custom ManufacturingFinished Dosage FormsPharmaceutical PackagingAPIs (Active Pharmaceutical Ingredients)
All Categories
PeptidesPhospholipidsCustom ManufacturingAPI Contract ManufacturingFinished Dosage FormsInjectablesParenteralsPharmaceutical PackagingAPIs (Active Pharmaceutical Ingredients)Vials / Cartridges / AmpoulesFilling/ Fill Finish & packagingInjectable systems and componentsContract Services
Corden Pharma InternationalCordenPharma is your One Partner CDMO for the global supply of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of fully-inspected cGMP facilities across Europe and the US organized under six technology platforms - Peptides - Oligonucleotides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-quality products. Discover more about our specialized capabilities in early phase GMP peptide clinical manufacturing targeted for INDs, Lipid NanoParticle (LNP) formulation, LNP Starter kits for design and optimization of LNP formulations, standard lipid catalog, bioavailability enhancement capabilities, oral solid dosage manufacturing, including oral peptide delivery, and expanded capabilities for aseptic and terminal sterile injectable manufacturing.

Log in

See all the content and easy-to-use features by logging in or registering!